FDA staff says Gilead's hepatitis C drug sofosbuvir safe, effective
This article was originally published in Scrip
Executive Summary
Gilead Sciences’ hepatitis C drug sofosbuvir is effective and appears to be safe, according to a review by FDA staff. The conclusion is an important vote of confidence as the therapy faces a review by a panel of US government advisers this week.